Advanced search
Publication Cover
Autoimmunity Volume 54, 2021 - Issue 4
Submit an article Journal homepage
236
Views
0
CrossRef citations to date
0
Altmetric
Short Communication

The prevalence and role of functional autoantibodies to angiotensin-converting-enzyme-2 in patients with systemic sclerosis

Bartosz Miziołeka Department of Dermatology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland;b Department of Internal Medicine Rheumatology and Clinical Immunology, School of Medicine in Katowice, Medical University of Silesia, Katowice, PolandCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8388-4419View further author information
ORCID Icon,
Marcin Sieńczykc Department of Organic and Medicinal Chemistry, Faculty of Chemistry, Wroclaw University of Science and Technology, Wrocław, PolandORCID Iconhttps://orcid.org/0000-0002-5528-5264View further author information
ORCID Icon,
Renata Grzywac Department of Organic and Medicinal Chemistry, Faculty of Chemistry, Wroclaw University of Science and Technology, Wrocław, PolandView further author information
,
Agnieszka Łupicka-Słowikc Department of Organic and Medicinal Chemistry, Faculty of Chemistry, Wroclaw University of Science and Technology, Wrocław, PolandView further author information
,
Eugeniusz Kucharzb Department of Internal Medicine Rheumatology and Clinical Immunology, School of Medicine in Katowice, Medical University of Silesia, Katowice, PolandView further author information
,
Przemysław Kotylab Department of Internal Medicine Rheumatology and Clinical Immunology, School of Medicine in Katowice, Medical University of Silesia, Katowice, PolandView further author information
&
Beata Bergler-Czopa Department of Dermatology, School of Medicine in Katowice, Medical University of Silesia, Katowice, PolandORCID Iconhttps://orcid.org/0000-0003-3788-5984View further author information
ORCID Icon show all
Pages 181-186 | Received 02 Feb 2021, Accepted 11 Apr 2021, Published online: 29 Apr 2021

References

  • Kayser C, Fritzler MJ. Autoantibodies in systemic sclerosis: unanswered questions. Front Immunol. 2015;6:167.
  • Berger M, Steen VD. Role of anti-receptor autoantibodies in pathophysiology of scleroderma. Autoimmun Rev. 2017;16(10):1029–1035.
  • Riemekasten G, Philippe A, Nather M, et al. Involvement of functional autoantibodies against vascular receptors in systemic sclerosis. Ann Rheum Dis. 2011;70(3):530–536.
  • Stanislav ML, Balabanova RM, Alekperov RT, et al. Autoantibodies to vasoactive peptides and angiotensin converting enzyme in patients with systemic diseases of the connective tissue. Ter Arkh. 2001;73:20–25.
  • Takahashi Y, Haga S, Ishizaka Y, et al. Autoantibodies to angiotensin-converting enzyme 2 in patients with connective tissue diseases. Arthritis Res Ther. 2010;12(3):R85.
  • Forrester SJ, Booz GW, Sigmund CD, et al. Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology. Physiol Rev. 2018;98(3):1627–1738.
  • Miziołek B, Bergler-Czop B, Kucharz E, et al. Significance of the angiotensin I/angiotensin II/angiotensin-(1–7) axis in the pathogenesis of systemic sclerosis. J Eur Acad Dermatol Venereol. 2020;34(3):558–564.
  • Pignone A, Rosso AD, Brosnihan KB, et al. Reduced circulating levels of angiotensin-(1–7) in systemic sclerosis: a new pathway in the dysregulation of endothelial-dependent vascular tone control. Ann Rheum Dis. 2007;66(10):1305–1310.
  • Moinzadeh P, Riemekasten G, Siegert E, German Network for Systemic Scleroderma, et al. Vasoactive therapy in systemic sclerosis: real-life therapeutic practice in more than 3000 patients. J Rheumatol. 2016;43(1):66–74.
  • Santos RAS, Sampaio WO, Alzamora AC, et al. The ACE2/angiotensin-(1–7)/MAS axis of the renin-angiotensin system: focus on angiotensin-(1–7). Physiol Rev. 2018;98(1):505–553.
  • Matucci-Cerinic M, Pignone A, Lotti T, et al. Reduced angiotensin converting enzyme plasma activity in scleroderma. A marker of endothelial injury? J Rheumatol. 1990;17(3):328–330.
  • Matucci-Cerinic M, Pignone A, Iannone F, et al. Clinical correlations of plasma angiotensin converting enzyme (ACE) activity in systemic sclerosis: a longitudinal study of plasma ACE level, endothelial injury and lung involvement. Respir Med. 1990;84(4):283–287.
  • Kawaguchi Y, Takagi K, Hara M, et al. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors. Arthritis Rheum. 2004;50(1):216–226.
  • Zhong JC, Basu R, Guo D, et al. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction. Circulation. 2010;122(7):717–728.
  • Wysocki J, Ye M, Rodriguez E, et al. Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension. Hypertens. 2010;55(1):90–98.
  • Varga J, Trojanowska M, Kuwana M. Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities. J Scleroderma Relat Disord. 2017;2(3):137–152.
  • Tang X, Geng L, Xuebing Feng X, et al. Decreased serum ACE2 levels in patients with connective tissue diseases. Rheumatology. 2021. doi:10.1093/rheumatology/keaa898.
  • Jia HP, Look DC, Ping Tan P, et al. Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia. Am J Physiol Lung Cell Mol Physiol. 2009; 297(1):L84–L96.
  • Domenig O, Manzel A, Grobe N, et al. Neprilysin is a mediator of alternative renin-angiotensin-system activation in the murine and human kidney. Sci Rep. 2016;6:33678.
  • Li W, Moore MJ, Vasilieva N, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003; 426(6965):450–454.
  • Casciola-Rosen L, Thiemann DR, Andrade F, et al. IgM autoantibodies recognizing ACE2 are associated with severe COVID-19. medRxiv. 2020. doi:10.1101/2020.10.13.20211664.
  • Elhai M, Avouac J, Kahan A, et al. Systemic sclerosis at the crossroad of polyautoimmunity. Autoimmun Rev. 2013;12(11):1052–1057.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.